Special Issue "Novel Magnetic Resonance Imaging (MRI) Techniques for Next Generation Molecular Imaging of Cancer"

A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Methods and Technologies Development".

Deadline for manuscript submissions: 30 September 2023 | Viewed by 209

Special Issue Editors

1. Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tübingen, 72076 Tübingen, Germany
2. Cluster of Excellence iFIT (EXC 2180) “Image-Guided and Functionally Instructed Tumor Therapies”, University of Tuebingen, 72076 Tübingen, Germany
3. German Cancer Consortium, DKFZ Partner Site Tübingen, 72076 Tübingen, Germany
Interests: multimodal imaging; metabolic imaging; hybrid PET-MRI imaging; metabolic sensors; metallomics
Special Issues, Collections and Topics in MDPI journals
1. Department of Nuclear Medicine, Klinikum Rechts der Isar, Technical University of Munich, 81675 München, Germany
2. German Cancer Consortium, DKTK Partner Site Munich, 80336 Munich, Germany
Interests: biomedical magnetic resonance; hyperpolarization techniques; hyperpolarized probe molecules; diffusion-weighted imaging; molecular imaging
1. German Cancer Consortium (DKTK), Partner Site Freiburg, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany
2. Division of Medical Physics, Department of Radiology, Medical Center, Faculty of Medicine, University of Freiburg, Killianstr. 5a, 79106 Freiburg, Germany
Interests: low field MRI and NMR; nuclear hyperpolarization; hyperpolarization method development

Special Issue Information

Dear Colleagues,

Cancer is one of the leading causes of death worldwide. Despite progress in cancer therapy through surgery, radiation, and targeted therapies, the clinical success of many anti-cancer strategies remains discouraging because the therapy is usually not tailored to the patient’s tumor biology. Treatment plans require a better understanding of the relationship between individual tumor biology and a therapeutic approach to improve patient outcomes. The need for novel technologies to progress from late-stage to early-stage detection and to match patients with the most promising therapeutic strategy is essential for precision medicine. Imaging biomarkers for cancer provide a quantitative and/or qualitative assessment of tumor biology images with spatial and temporal resolution. The development of molecular imaging techniques to depict physiological, metabolic, and cellular processes within tumors is needed for treatment selection and to predict tumor response to treatment, before conventional changes in tumor size can be measured. In this Special Issue, we want to highlight “Novel Magnetic Resonance Imaging (MRI) Techniques for Next Generation Molecular Imaging of Cancer, including hyperpolarized MR, CEST, multimodal PET/MRI, MR contrast agents, and functional imaging.

Prof. Dr. Andre F. Martins
Prof. Dr. Franz Schilling
Dr. Andreas Benjamin Schmidt
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • cancer
  • molecular imaging
  • functional imaging
  • MRI
  • hyperpolarization
  • biosensors
  • metabolism
  • dDNP
  • PHIP
  • SEOP
  • parahydrogen

Published Papers

This special issue is now open for submission.
Back to TopTop